Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial

Stocks Yahoo Finance By Yahoo Finance 21 May 2026 02:49 1 min read

Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial

Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial

Immunovant (IMVT) Hits 5-Year High on Stellar Arthritis Treatment Trial

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.